(Q22306309)

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

The epidemiology of sepsis in the United States from 1979 through 2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Critical illness-related corticosteroid insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: a Bayesian meta-analytic perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Corticosteroids for sepsis: registry versus Cochrane systematic review!

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Adrenal function in sepsis: the retrospective Corticus cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Steroid therapy of septic shock: the decision is in the eye of the beholder

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Use of corticosteroid therapy in patients with sepsis and septic shock: an evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

From mega to more reasonable doses of corticosteroids: a decade to recreate hope.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Corticosteroids in septic shock: resurrection of the last rites?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

The altered adrenal axis and treatment with glucocorticoids during critical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Intensive insulin therapy and pentastarch resuscitation in severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Intensive versus conventional glucose control in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Treatment of dopamine-dependent shock with triiodothyronine

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Measurements of serum free cortisol in critically ill patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Hypothalamic pituitary adrenal function during critical illness: limitations of current assessment methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Adrenal function testing in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Relative adrenal insufficiency in patients with septic shock: comparison of low-dose and conventional corticotropin tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Steroid therapy of septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Adrenal insufficiency in critically ill patients with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Steroids for septic shock: back from the dead? (Con).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Steroids for septic shock: back from the dead? (Pro).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Use of corticosteroids in treating infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Reversal of late septic shock with supraphysiologic doses of hydrocortisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Physiological-dose steroid therapy in sepsis [ISRCTN36253388]

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Global utilization of low-dose corticosteroids in severe sepsis and septic shock: a report from the PROGRESS registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Hydrocortisone therapy for patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

Adrenal axis function does not appear to be associated with hemodynamic improvement in septic shock patients systematically receiving glucocorticoid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

7 January 2021

The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

7 January 2021

Steroids in the treatment of clinical septic shock

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

7 January 2021

Diagnosis of adrenal insufficiency in severe sepsis and septic shock

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201011-1897CI

7 January 2021

10.1164/RCCM.201011-1897CI

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

2872558

2872558

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference